(TLX) Talanx - Overview
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE000TLX1005
Stock: Insurance, Reinsurance, Life, Property, Casualty
Total Rating 27
Risk 33
Buy Signal -1.53
| Risk 5d forecast | |
|---|---|
| Volatility | 32.5% |
| Relative Tail Risk | -6.07% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.37 |
| Alpha | 2.47 |
| Character TTM | |
|---|---|
| Beta | 0.381 |
| Beta Downside | 0.396 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.11% |
| CAGR/Max DD | 2.19 |
EPS (Earnings per Share)
Revenue
Description: TLX Talanx March 05, 2026
Talanx AG is a German insurance company. It offers a wide range of insurance and reinsurance products globally.
The companys offerings span various insurance types, including life, casualty, property, and specialized coverage like aviation and cyber risks. Reinsurance, a core component of the insurance industry, involves insurers transferring portions of their risk portfolios to other insurers.
Talanx also provides bancassurance products, which are insurance products distributed through banks, and engages in asset management. The companys diverse portfolio reflects the multi-line insurance business model, which aims to diversify risk and revenue streams across different insurance segments. For further detailed analysis, explore ValueRay.
Headlines to watch out for
- Premium growth in property/casualty insurance boosts revenue
- Reinsurance segment performance impacts profitability
- Investment income fluctuations affect overall earnings
- Natural catastrophe events increase claims payouts
- Regulatory changes in insurance sector pose compliance risks
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 2.35b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.43 > 1.0 |
| NWC/Revenue: 30.44% < 20% (prev 7.31%; Δ 23.13% < -1%) |
| CFO/TA 0.07 > 3% & CFO 12.01b > Net Income 2.35b |
| Net Debt (3.62b) to EBITDA (5.39b): 0.67 < 3 |
| Current Ratio: 6.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (258.2m) vs 12m ago 0.24% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 14.08% > 50% (prev 16.78%; Δ -2.70% > 0%) |
| Interest Coverage Ratio: 4.60 > 6 (EBITDA TTM 5.39b / Interest Expense TTM 280.0m) |
Altman Z'' 0.58
| A: 0.04 (Total Current Assets 9.20b - Total Current Liabilities 1.52b) / Total Assets 179.50b |
| B: 0.06 (Retained Earnings 10.35b / Total Assets 179.50b) |
| C: 0.01 (EBIT TTM 1.29b / Avg Total Assets 179.20b) |
| D: 0.06 (Book Value of Equity 9.98b / Total Liabilities 159.90b) |
| Altman-Z'' Score: 0.58 = B |
Beneish M 1.00
| DSRI: 10.16 (Receivables 9.20b/1.08b, Revenue 25.23b/30.02b) |
| GMI: 1.06 (GM 100.0% / 106.5%) |
| AQI: 0.98 (AQ_t 0.94 / AQ_t-1 0.97) |
| SGI: 0.84 (Revenue 25.23b / 30.02b) |
| TATA: -0.05 (NI 2.35b - CFO 12.01b) / TA 179.50b) |
| Beneish M-Score: 4.39 (Cap -4..+1) = D |
What is the price of TLX shares?
As of March 21, 2026, the stock is trading at EUR 104.20 with a total of 338,783 shares traded.
Over the past week, the price has changed by -1.51%, over one month by -4.14%, over three months by -8.36% and over the past year by +9.69%.
Over the past week, the price has changed by -1.51%, over one month by -4.14%, over three months by -8.36% and over the past year by +9.69%.
Is TLX a buy, sell or hold?
Talanx has no consensus analysts rating.
What are the forecasts/targets for the TLX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 117 | 12.3% |
| Analysts Target Price | - | - |
TLX Fundamental Data Overview March 19, 2026
Market Cap USD = 32.68b (28.51b EUR * 1.1464 EUR.USD)
P/E Trailing = 12.1452
P/E Forward = 10.6838
P/S = 0.676
P/B = 2.1614
P/EG = 0.8757
Revenue TTM = 25.23b EUR
EBIT TTM = 1.29b EUR
EBITDA TTM = 5.39b EUR
Long Term Debt = 8.37b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 293.0m EUR (from shortTermDebt, last fiscal year)
Debt = 8.90b EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 3.62b EUR (from netDebt column, last fiscal year)
Enterprise Value = -85.93b EUR (28.51b + Debt 8.90b - CCE 123.34b)
Interest Coverage Ratio = 4.60 (Ebit TTM 1.29b / Interest Expense TTM 280.0m)
EV/FCF = -10.19x (Enterprise Value -85.93b / FCF TTM 8.43b)
FCF Yield = -9.81% (FCF TTM 8.43b / Enterprise Value -85.93b)
FCF Margin = 33.42% (FCF TTM 8.43b / Revenue TTM 25.23b)
Net Margin = 9.31% (Net Income TTM 2.35b / Revenue TTM 25.23b)
Gross Margin = unknown ((Revenue TTM 25.23b - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = -0.48 (set to none) (Enterprise Value -85.93b / Total Assets 179.50b)
Interest Expense / Debt = 0.04% (Interest Expense 4.00m / Debt 8.90b)
Taxrate = 30.72% (239.0m / 778.0m)
NOPAT = 892.3m (EBIT 1.29b * (1 - 30.72%))
Current Ratio = 6.05 (Total Current Assets 9.20b / Total Current Liabilities 1.52b)
Debt / Equity = 0.70 (Debt 8.90b / totalStockholderEquity, last quarter 12.70b)
Debt / EBITDA = 0.67 (Net Debt 3.62b / EBITDA 5.39b)
Debt / FCF = 0.43 (Net Debt 3.62b / FCF TTM 8.43b)
Total Stockholder Equity = 12.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.31% (Net Income 2.35b / Total Assets 179.50b)
RoE = 19.37% (Net Income TTM 2.35b / Total Stockholder Equity 12.13b)
RoCE = 6.28% (EBIT 1.29b / Capital Employed (Equity 12.13b + L.T.Debt 8.37b))
RoIC = 5.52% (NOPAT 892.3m / Invested Capital 16.18b)
WACC = 5.59% (E(28.51b)/V(37.41b) * Re(7.32%) + D(8.90b)/V(37.41b) * Rd(0.04%) * (1-Tc(0.31)))
Discount Rate = 7.32% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF] Terminal Value 86.06% ; FCFF base≈8.11b ; Y1≈7.90b ; Y5≈7.93b
[DCF] Fair Price = 904.4 (EV 237.17b - Net Debt 3.62b = Equity 233.55b / Shares 258.2m; r=5.90% [WACC]; 5y FCF grow -3.72% → 2.90% )
EPS Correlation: 82.57 | EPS CAGR: 20.42% | SUE: -1.10 | # QB: 0
Revenue Correlation: -24.30 | Revenue CAGR: 23.47% | SUE: 0.93 | # QB: 1
EPS next Year (2026-12-31): EPS=10.47 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+12.0% | Growth Revenue=+4.7%
P/E Trailing = 12.1452
P/E Forward = 10.6838
P/S = 0.676
P/B = 2.1614
P/EG = 0.8757
Revenue TTM = 25.23b EUR
EBIT TTM = 1.29b EUR
EBITDA TTM = 5.39b EUR
Long Term Debt = 8.37b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 293.0m EUR (from shortTermDebt, last fiscal year)
Debt = 8.90b EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 3.62b EUR (from netDebt column, last fiscal year)
Enterprise Value = -85.93b EUR (28.51b + Debt 8.90b - CCE 123.34b)
Interest Coverage Ratio = 4.60 (Ebit TTM 1.29b / Interest Expense TTM 280.0m)
EV/FCF = -10.19x (Enterprise Value -85.93b / FCF TTM 8.43b)
FCF Yield = -9.81% (FCF TTM 8.43b / Enterprise Value -85.93b)
FCF Margin = 33.42% (FCF TTM 8.43b / Revenue TTM 25.23b)
Net Margin = 9.31% (Net Income TTM 2.35b / Revenue TTM 25.23b)
Gross Margin = unknown ((Revenue TTM 25.23b - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = -0.48 (set to none) (Enterprise Value -85.93b / Total Assets 179.50b)
Interest Expense / Debt = 0.04% (Interest Expense 4.00m / Debt 8.90b)
Taxrate = 30.72% (239.0m / 778.0m)
NOPAT = 892.3m (EBIT 1.29b * (1 - 30.72%))
Current Ratio = 6.05 (Total Current Assets 9.20b / Total Current Liabilities 1.52b)
Debt / Equity = 0.70 (Debt 8.90b / totalStockholderEquity, last quarter 12.70b)
Debt / EBITDA = 0.67 (Net Debt 3.62b / EBITDA 5.39b)
Debt / FCF = 0.43 (Net Debt 3.62b / FCF TTM 8.43b)
Total Stockholder Equity = 12.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.31% (Net Income 2.35b / Total Assets 179.50b)
RoE = 19.37% (Net Income TTM 2.35b / Total Stockholder Equity 12.13b)
RoCE = 6.28% (EBIT 1.29b / Capital Employed (Equity 12.13b + L.T.Debt 8.37b))
RoIC = 5.52% (NOPAT 892.3m / Invested Capital 16.18b)
WACC = 5.59% (E(28.51b)/V(37.41b) * Re(7.32%) + D(8.90b)/V(37.41b) * Rd(0.04%) * (1-Tc(0.31)))
Discount Rate = 7.32% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF] Terminal Value 86.06% ; FCFF base≈8.11b ; Y1≈7.90b ; Y5≈7.93b
[DCF] Fair Price = 904.4 (EV 237.17b - Net Debt 3.62b = Equity 233.55b / Shares 258.2m; r=5.90% [WACC]; 5y FCF grow -3.72% → 2.90% )
EPS Correlation: 82.57 | EPS CAGR: 20.42% | SUE: -1.10 | # QB: 0
Revenue Correlation: -24.30 | Revenue CAGR: 23.47% | SUE: 0.93 | # QB: 1
EPS next Year (2026-12-31): EPS=10.47 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+12.0% | Growth Revenue=+4.7%